Alupent and Movement - uncoordinated - a phase IV clinical study of FDA data

Summary:

Movement - uncoordinated is reported as a side effect among people who take Alupent (metaproterenol sulfate), especially for people who are female, 60+ old, also take Detrol, and have Bone disorder.

The phase IV clinical study analyzes which people have Movement - uncoordinated when taking Alupent. It is created by eHealthMe based on reports of 599 people who have side effects when taking Alupent from the FDA, and is updated regularly.

What is Alupent?

Alupent has active ingredients of metaproterenol sulfate. eHealthMe is studying from 604 Alupent users. Check the latest studies of Alupent.

What is Movement - uncoordinated?

Movement - uncoordinated is found to be associated with 1,106 drugs and 2,267 conditions by eHealthMe. Check the latest studies of Movement - uncoordinated.

On Jul, 14, 2026

599 people reported to have side effects when taking Alupent.
Among them, 11 people (1.84%) have Movement - uncoordinated.

Could Alupent cause Movement - uncoordinated?

Among these 11 people:

What is the gender of people who have Movement - uncoordinated when taking Alupent? *

female: 90.91 %
male: 9.09 %

What is the age of people who have Movement - uncoordinated when taking Alupent? *

What are other drugs people take besides Alupent? *

What are other side effects people have besides Movement - uncoordinated? *

Cataract (clouding of the lens inside the eye): 10 people, 90.91%
Cough: 10 people, 90.91%
Mastication Disorder (disease of chewing food): 10 people, 90.91%
Cellulitis (infection under the skin): 10 people, 90.91%
Kidney Infection (Pyelonephritis): 10 people, 90.91%
Cerebral Artery Stenosis (hardening of brain blood vessels): 10 people, 90.91%
Cerebrosclerosis (hardening of the substance of the cerebrum): 10 people, 90.91%
Incontinence (lack of moderation or self-control): 10 people, 90.91%
Incisional Drainage: 10 people, 90.91%
Impaired Healing: 10 people, 90.91%

What are the existing conditions these people have? *

Stress And Anxiety: 10 people, 90.91%
Pain: 10 people, 90.91%
Metastases To Bone (cancer spreads to bone): 10 people, 90.91%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 10 people, 90.91%
Gout (uric acid crystals building up in the body): 10 people, 90.91%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 10 people, 90.91%
Dizziness: 10 people, 90.91%
Breast Cancer: 10 people, 90.91%
Bone Pain: 10 people, 90.91%
Bone Disorder: 10 people, 90.91%

* Approximation only. Some reports may have incomplete information.

Do you take Alupent and have Movement - uncoordinated?

- Check whether Movement - uncoordinated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Alupent:

Alupent (604 reports)

Browse all side effects of Alupent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Movement - uncoordinated:

Movement - uncoordinated (1,106 drugs)

Browse all the conditions that are associated with Movement - uncoordinated:

Movement - uncoordinated (2,267 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on metaproterenol sulfate (the active ingredients of Alupent) and Alupent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.